All trials
NCT05552157PHASE2RECRUITING

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Eligibility check — Phoenix members

Phoenix members see for THIS trial:

  • APOE genotype match
  • Cognitive status fits inclusion
  • Specific exclusions flagged
  • Distance to nearest site
Check my eligibility — become a member
Sites
35 locations
Start
2024-11-22

Interventions tested

  • DRUGRemternetug (SC)
  • DRUGMatching Placebo (Remternetug)
View full record on ClinicalTrials.gov

We use cookies to enhance your experience.